Recombinant Yersinia pestis bv. Antiqua UPF0208 membrane protein YPN_2157 (YPN_2157)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Yersinia pestis bv. Antiqua UPF0208 Membrane Protein YPN_2157 (YPN_2157)

Recombinant Yersinia pestis bv. Antiqua UPF0208 membrane protein YPN_2157 (YPN_2157) is a protein derived from Yersinia pestis bv. Antiqua, expressed in a recombinant form and tagged with histidine (His) . Yersinia pestis is the bacterium that causes plague, a severe and sometimes fatal infectious disease in humans and animals .

Characteristics

CharacteristicDescription
Source OrganismYersinia pestis bv. Antiqua
Protein TypeUPF0208 membrane protein YPN_2157
ExpressionRecombinant, expressed in E. coli
TagN-terminal His tag
Length1-151 amino acids

Structure of Proteins

Proteins have four levels of structure: primary, secondary, tertiary, and quaternary2.

Function and Role in Yersinia pestis**

Yersinia pestis employs a Type III secretion system (T3SS) to inject virulence effectors into host cells . This system involves more than 20 proteins that form a syringe-like structure . These proteins modulate cellular functions in the host . Several Yersinia outer proteins (Yops) are crucial virulence factors . These proteins have various functions, including cytotoxicity, interference with host cell signaling, and immune evasion .

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to pellet the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a guideline.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during production. If a specific tag type is required, please inform us for preferential development.
Synonyms
YPN_2157; YP516_2410; UPF0208 membrane protein YPN_2157
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-151
Protein Length
full length protein
Species
Yersinia pestis bv. Antiqua (strain Nepal516)
Target Names
YPN_2157
Target Protein Sequence
MTIKPSDSVSWFQVLQRGQHYMKTWPADKRLAPVFPENRVTVVTRFGIRFMPPLAIFTLT WQIALGGQLGPAIATALFACGLPLQGLWWLGKRAITPLPPTLLQWFHEVRHKLFEAGQAV APIEPIPTYQSLADLLKRAFKQLDKTFLDDL
Uniprot No.

Target Background

Database Links

KEGG: ypn:YPN_2157

Protein Families
UPF0208 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is YPN_2157 and what experimental approaches can characterize its function?

YPN_2157 is a UPF0208 membrane protein from Yersinia pestis biovar Antiqua with UniProt ID Q1CHP4. It consists of 151 amino acids with the sequence: MTIKPSDSVSWFQVLQRGQHYMKTWPADKRLAPVFPENRVTVVTRFGIRFMPPLAIFTLTWQIALGGQLGPAIATALFACGLPLQGLWWLGKRAITPLPPTLLQWFHEVRHKLFEAGQAVAPIEPIPTYQSLADLLKRAFKQLDKTFLDDL .

For functional characterization, researchers should consider:

  • Membrane localization studies using GFP fusion constructs

  • Protein-protein interaction assays (pull-down, co-immunoprecipitation)

  • Gene knockout studies to observe phenotypic changes

  • Structure-function relationship analysis using site-directed mutagenesis

When designing these experiments, define your variables clearly before proceeding - independent variables (e.g., expression levels, mutation sites) and dependent variables (e.g., growth rates, binding affinity) .

How should researchers optimize expression of recombinant YPN_2157?

  • Expression system selection: While E. coli is the default system, consider alternative expression hosts for membrane proteins if yield is low.

  • Expression conditions:

    ParameterRange to TestConsiderations
    Temperature16-37°CLower temperatures reduce inclusion body formation
    Induction time2-24 hoursMonitor expression at multiple timepoints
    Inducer concentration0.1-1.0 mM IPTGTitrate to optimize yield vs. solubility
    Media compositionLB, TB, 2xYTRich media may increase yield
  • Solubilization optimization: Test multiple detergents (DDM, LDAO, etc.) for extraction efficiency

  • Purification strategy: Implement two-step purification (IMAC followed by size exclusion chromatography)

Control for extraneous variables by maintaining consistent cell density at induction and standardizing lysis procedures to ensure experimental reproducibility .

What are the critical variables to control when studying YPN_2157 membrane interactions?

When designing experiments to investigate YPN_2157 membrane interactions, researchers must control these key variables:

  • Lipid composition: Match experimental membrane systems to bacterial membrane composition

    Membrane ComponentConsideration
    Phospholipid ratioPE:PG:CL ratios affect protein insertion
    Lipid chain lengthAffects hydrophobic matching with protein
    Cholesterol contentMinimal in bacterial membranes but may affect fluidity
  • Buffer conditions: pH, ionic strength, and specific ions can dramatically affect membrane protein behavior

  • Temperature: Maintain physiologically relevant conditions (37°C) or test a range

  • Protein:lipid ratio: Critical for reconstitution experiments

When planning these experiments, consider both between-subjects designs (comparing different mutants) and within-subjects designs (same protein under varying conditions) . Document all controlled variables in your Table 1 to allow readers to assess both internal and external validity of your findings .

How should researchers approach sample preparation and storage to maintain YPN_2157 stability?

Proper handling of recombinant YPN_2157 is critical for experimental reproducibility. Follow these methodological guidelines:

  • Reconstitution procedure:

    • Reconstitute lyophilized protein in deionized sterile water to 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 5-50% (50% is recommended)

    • Aliquot immediately after reconstitution to prevent freeze-thaw cycles

  • Storage protocol:

    • Store at -20°C/-80°C for long-term storage

    • For working stocks, maintain at 4°C for up to one week

    • Avoid repeated freeze-thaw cycles as they significantly reduce protein activity

  • Quality control measures:

    • Verify protein integrity by SDS-PAGE before experiments (should show >90% purity)

    • Consider thermal shift assays to confirm proper folding

    • Document storage conditions and time in your experimental methods

In your experimental design, implement controls to account for potential batch-to-batch variation, and include handling time as a potential confounding variable in your analysis .

What structural biology techniques are most appropriate for studying YPN_2157?

For structural characterization of YPN_2157, consider these methodological approaches based on research questions:

  • Secondary structure analysis:

    • Circular dichroism (CD) spectroscopy to quantify alpha-helical content

    • FTIR spectroscopy for membrane-embedded protein

  • Tertiary structure determination:

    TechniqueResolutionAdvantagesLimitations
    X-ray crystallography1.5-3.0 ÅHigh resolutionChallenging crystallization
    Cryo-EM2.5-4.0 ÅNo crystallization neededSample preparation challenges
    NMR spectroscopyAtomic levelDynamic informationSize limitations
    Molecular dynamicsAtomic levelMembrane environmentComputational model
  • Membrane topology mapping:

    • Cysteine scanning mutagenesis

    • Protease accessibility assays

    • Fluorescence quenching experiments

When designing structural biology experiments, consider how detergent choice or membrane mimetic systems might influence protein conformation. Document these choices carefully in your methods and Table 1 to allow proper assessment of validity .

How can researchers effectively analyze YPN_2157 within complex biological systems?

Studying YPN_2157 in complex systems requires sophisticated experimental approaches:

  • In vivo localization:

    • Super-resolution microscopy (STORM, PALM) with fluorescent tags

    • Spatial proteomics with subcellular fractionation

    • Proximity labeling techniques (BioID, APEX)

  • Interaction network mapping:

    • Bacterial two-hybrid systems

    • Cross-linking mass spectrometry (XL-MS)

    • Co-evolution analysis with bioinformatics

  • Functional genomics approaches:

    • CRISPR interference in model bacteria

    • Transposon mutagenesis screens

    • Conditional depletion systems

When conducting these complex experiments, control for multiple variables simultaneously and consider interaction effects. Your analytical design should account for both the main effects of each variable and their potential interactions . Document missing data handling approaches explicitly in both your methods and descriptive statistics .

What statistical approaches should be used when analyzing YPN_2157 functional data?

When analyzing functional data for YPN_2157, implement these statistical approaches:

  • Data preprocessing:

    • Check for normality using Shapiro-Wilk test

    • Transform data if necessary (log, Box-Cox)

    • Remove outliers only with biological justification

  • Statistical testing:

    Experimental DesignAppropriate TestConsiderations
    Two conditionsStudent's t-test or Mann-WhitneyCheck assumptions
    Multiple conditionsANOVA with post-hoc testsControl for multiple comparisons
    Dose-responseNonlinear regressionSelect appropriate model
    Time-seriesRepeated measures ANOVAAccount for temporal correlation
  • Reporting requirements:

    • Include measures of variability (SD, SEM)

    • Report exact p-values rather than thresholds

    • Include sample sizes and power calculations

When reporting statistical results in publications, structure your Table 1 to show distributions of key variables within sample strata to maximize transparency for assessing internal validity . This approach allows readers to evaluate the robustness of your findings.

How should researchers present comprehensive YPN_2157 data in scientific publications?

Effective data presentation for YPN_2157 research should follow these methodological guidelines:

For effective presentation in the "People also ask" format, structure your answers to directly address the question immediately in the first sentence . This approach improves the likelihood of your research being correctly indexed and visible in search results.

How can researchers address data inconsistencies in YPN_2157 experiments?

When confronting inconsistent results in YPN_2157 research, implement this systematic approach:

  • Validate reagents and materials:

    • Confirm protein identity by mass spectrometry

    • Verify recombinant protein quality by SDS-PAGE

    • Test multiple protein batches to rule out preparation issues

  • Experimental factors to investigate:

    FactorInvestigation MethodCommon Issues
    Buffer compositionSystematic screeningIonic strength, pH effects
    Protein concentrationDilution seriesAggregation at high concentrations
    Detergent effectsCompare multiple detergentsFunctional interference
    Temperature sensitivityThermal stability assaysDenaturation, aggregation
  • Documentation practices:

    • Maintain detailed lab notebooks with exact protocols

    • Record lot numbers for all reagents

    • Document environmental conditions (temperature, humidity)

  • Statistical approaches:

    • Conduct sensitivity analyses with different data subsets

    • Consider mixed-effects models to account for batch variation

    • Report heterogeneity transparently in publications

When reporting results with inconsistencies, modify your Table 1 to show key variables across different experimental conditions, allowing readers to evaluate potential sources of variation . This transparency strengthens the credibility of your findings despite experimental challenges.

What emerging technologies might advance YPN_2157 research?

Several cutting-edge methodologies show promise for advancing YPN_2157 research:

  • Structural biology innovations:

    • Microcrystal electron diffraction (MicroED) for membrane proteins

    • Integrative structural biology combining multiple data sources

    • AI-powered structure prediction (AlphaFold2) for function prediction

  • Single-molecule techniques:

    • smFRET for conformational dynamics

    • Single-molecule force spectroscopy for mechanical properties

    • Nanodiscs for native-like membrane environments

  • Spatiotemporal analysis:

    • Live-cell super-resolution microscopy

    • Mass photometry for stoichiometry determination

    • Correlative light and electron microscopy (CLEM)

When designing experiments with these emerging technologies, carefully consider their technical limitations and build appropriate controls into your experimental design . Document both successful and unsuccessful methodological approaches to guide future researchers in this field.

How can researchers effectively integrate YPN_2157 findings with broader Yersinia pestis pathogenesis research?

To contextualize YPN_2157 research within the broader understanding of Y. pestis:

  • Systems biology approaches:

    • Multi-omics integration (transcriptomics, proteomics, metabolomics)

    • Network analysis of protein-protein interactions

    • Host-pathogen interaction modeling

  • Translational connections:

    Research AreaIntegration ApproachPotential Impact
    Virulence mechanismsCorrelate YPN_2157 function with pathogenicityTarget identification
    Environmental survivalTest YPN_2157 role in stress responsesTransmission insights
    Host immune interactionsExamine YPN_2157 immunogenicityVaccine development
  • Collaborative frameworks:

    • Establish standardized protocols across research groups

    • Develop shared reagent repositories

    • Implement open data sharing practices

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.